Profile of Reactive Estrogen Species in Women with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Bodor, J. N. [1 ]
Krzizike, D. D. [1 ]
Vanderveer, L. [1 ]
Eidbo, S. [1 ]
Zawislak, C. L. [1 ]
Ross, E. A. [1 ]
Andrews, A. J. [2 ]
Edelman, M. J. [1 ]
Treat, J. [1 ]
Clapper, M. L. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Univ North Carolina Wilmington, Wilmington, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR; Reactive Catechols; Estrogen; Metabolism;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA13.04
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [2] Emerging drugs for EGFR-mutated non-small cell lung cancer
    Sukrithan, Vineeth
    Deng, Lei
    Barbar, Alexander
    Cheng, Haiying
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (01) : 5 - 16
  • [3] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [4] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [6] Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Ou, S.
    Klempner, S.
    Creelan, B.
    Hsieh, W. S.
    Costin, D.
    Stephens, P. J.
    Ross, J.
    Miller, V.
    Ali, S.
    Schrock, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1848 - S1848
  • [7] Deciphering the Characterization of Tumor Microenvironment in EGFR-Mutated Non-Small Cell Lung Cancer
    Qiao, M.
    Jiang, T.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S182 - S183
  • [8] Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Soo, Ross A.
    Wolf, Juergen
    Solomon, Benjamin J.
    Tan, Daniel S. W.
    Ardizzoni, Andrea
    Lee, Dae Ho
    Sequist, Lecia V.
    Barlesi, Fabrice
    Ponce-Aix, Santiago
    Abreu, Delvys Rodriguez
    Campelo, Maria Rosario Garcia
    Sprauten, Mette
    Djentuh, Leslie O'Sullivan
    Smith, Nathalie
    Jary, Aline
    Belli, Riccardo
    Glaser, Sabine
    Zou, Mike
    Cui, Xiaoming
    Giovannini, Monica
    Yang, James Chih-Hsin
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [9] Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
    Steendam, Christi M. J.
    Veerman, G. D. Marijn
    Pruis, Melinda A.
    Atmodimedjo, Peggy
    Paats, Marthe S.
    van der Leest, Cor
    von der Thusen, Jan H.
    Yick, David C. Y.
    Oomen-de Hoop, Esther
    Koolen, Stijn L. W.
    Dinjens, Winand N. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Aerts, Joachim G. J. V.
    Dubbink, Hendrikus Jan
    Dingemans, Anne-Marie C.
    CANCERS, 2020, 12 (11) : 1 - 17
  • [10] Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
    Eltayeb, Kamal
    La Monica, Silvia
    Tiseo, Marcello
    Alfieri, Roberta
    Fumarola, Claudia
    CELLS, 2022, 11 (03)
12345